Itraconazole halts hepatocellular carcinoma progression by modulating sonic hedgehog signaling in rats: A novel therapeutic approach
Osama A. Mohammed,Ahmed S. Doghish,Lobna A. Saleh,Mushabab Alghamdi,Mohannad Mohammad S. Alamri,Jaber Alfaifi,Masoud I.E. Adam,Muffarah Hamid Alharthi,Abdullah M. Alshahrani,Abdullah Hassan Alhalafi,Waad Fuad BinAfif,Assad Ali Rezigalla,Mustafa Ahmed Abdel-Reheim,Hend S. El-wakeel,Mohammed A. Attia,Elsayed A. Elmorsy,Tohada M. AL-Noshokaty,Yousra Nomier,Sameh Saber
DOI: https://doi.org/10.1016/j.prp.2023.155086
IF: 3.309
2024-01-05
Pathology - Research and Practice
Abstract:Liver cancer stands as the fourth leading global cause of death, and its prognosis remains grim due to the limited effectiveness of current medical interventions. Among the various pathways implicated in the development of hepatocellular carcinoma (HCC), the hedgehog signaling pathway has emerged as a crucial player. Itraconazole , a relatively safe and cost-effective antifungal medication, has gained attention for its potential as an anticancer agent. Its primary mode of action involves inhibiting the hedgehog pathway, yet its impact on HCC has not been elucidated. The main objective of this study was to investigate the effect of itraconazole on diethylnitrosamine-induced early-stage HCC in rats. Our findings revealed that itraconazole exhibited a multifaceted arsenal against HCC by downregulating the expression of key components of the hedgehog pathway, shh , smoothened (SMO), and GLI family zinc finger 1 (GLI1), and GLI2. Additionally, itraconazole extended survival and improved liver tissue structure, attributed mainly to its inhibitory effects on hedgehog signaling. Besides, itraconazole demonstrated a regulatory effect on Notch1 , and Wnt/β-catenin signaling molecules. Consequently, itraconazole displayed diverse anticancer properties, including anti-inflammatory, antiangiogenic, antiproliferative, and apoptotic effects, as well as the potential to induce autophagy. Moreover, itraconazole exhibited a promise to impede the transformation of epithelial cells into a more mesenchymal-like phenotype. Overall, this study emphasizes the significance of targeting the hedgehog pathway with itraconazole as a promising avenue for further exploration in clinical studies related to HCC treatment.
pathology